The EphA2 signaling caused reduced expression of transcription factor cdx-2 that hinder its binding to claudin promoter and thus cause irregular expression of claudin-2 which is reported to be increased in NSCLC cells in the present study. The gene discussed is CDX2; the disease is non-small cell lung carcinoma.